Boston Scientific Gets Approval For Throat Stent In U.S., E.U.

Boston Scientific is cleared to place its WallFlex esophageal stent on the market in the United States and Europe after receiving regulatory approval in both venues. Boston Scientific developed the stent for use in esophageal-cancer patients. Such patients can develop obstructions in their throats, treatable with the stents. (Click here for more)

“Boston Scientific OK’d To Market WallFlex Stent” – Boston Globe (11/21/09)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!